What is in this blend?
This vial combines three research peptides, with 12mg of peptide in total.
- HGH Fragment 176-191: a 16-amino-acid peptide matching the C-terminal end of human growth hormone.
- Mod GRF 1-29 (CJC-1295 without DAC): GHRH(1-29) with four amino-acid substitutions, which acts on the GHRH receptor.
- Ipamorelin: a synthetic pentapeptide that acts selectively on the ghrelin (GHS) receptor.
This blend vs the CJC-1295 version
This blend always contains CJC-1295 without DAC (Mod GRF 1-29), which has no albumin-binding linker and is cleared within minutes to hours. Our Fragment 176-191, CJC-1295 & Ipamorelin Blend is listed under the general name “CJC-1295”, which can also mean the longer-acting form with DAC (a drug affinity complex that binds albumin and extends half-life to several days). The Fragment 176-191 and ipamorelin parts and the 12mg total are the same. Ask us which form a batch contains if you are comparing the two.
Regulatory status
None of these peptides is an approved medicine. GHRH analogues and growth hormone secretagogues are prohibited at all times in competitive sport by the World Anti-Doping Agency. This product is sold for laboratory research use only.
Related products
- Each peptide on its own: HGH Fragment 176-191, Mod GRF 1-29 and Ipamorelin.
- Also available: Fragment 176-191, CJC-1295 & Ipamorelin Blend and Mod GRF 1-29 & Ipamorelin Blend.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
